Department of Epidemiology and Health Services Research, Geisinger Health System, Danville, Pa.
Department of Epidemiology and Health Services Research, Geisinger Health System, Danville, Pa.
J Allergy Clin Immunol Pract. 2018 Jul-Aug;6(4):1327-1335.e3. doi: 10.1016/j.jaip.2017.10.012. Epub 2017 Nov 10.
Chronic rhinosinusitis (CRS) is a prevalent and disabling condition of the nose and sinuses. The natural history of CRS symptoms in a general population sample has not been previously studied.
In a general population-based sample from Pennsylvania, we used 2 questionnaires mailed 6 months apart to estimate the prevalence of, and identify predictors for, stability or change in symptoms over time.
We mailed the baseline and 6-month follow-up questionnaires to 23,700 primary care patients and 7,801 baseline responders, respectively. We categorized nasal and sinus symptoms using European Position Paper on Rhinosinusitis (EPOS) epidemiologic criteria. We defined 6 symptom groups over time on the basis of the presence of CRS symptoms at baseline and follow-up. We performed multivariable survey logistic regression controlling for confounding variables comparing persistent versus nonpersistent, recurrent versus stable past, and incident versus never.
There were 4,966 responders at follow-up: 558 had persistent symptoms, 190 recurrent symptoms, and 83 new symptoms meeting EPOS criteria for CRS. The prevalence of persistent symptoms was 4.8% (95% CI, 3.8-5.8), whereas the annual cumulative incidence of new symptoms was 1.9% and of recurrent symptoms was 3.2%. More severe symptoms at baseline were associated with persistence, whereas minor symptoms, allergies, and multiple treatments were associated with the development of new symptoms.
Less than half with nasal and sinus symptoms meeting CRS EPOS criteria in our general, regional population had symptom persistence over time, with symptom profiles at baseline and age of onset being strongly associated with stability of symptoms.
慢性鼻-鼻窦炎(CRS)是一种常见且使人丧失能力的鼻部和鼻窦疾病。尚未对一般人群中 CRS 症状的自然病史进行过研究。
在宾夕法尼亚州的一项基于一般人群的样本中,我们使用了 2 份相隔 6 个月寄出的问卷,以评估症状随时间的稳定性或变化,并确定其预测因素。
我们分别向 23700 名初级保健患者和 7801 名基线应答者邮寄了基线和 6 个月随访问卷。我们使用欧洲鼻-鼻窦炎诊疗意见书(EPOS)的流行病学标准对鼻和鼻窦症状进行分类。我们根据基线和随访时是否存在 CRS 症状,将 6 个时间点的症状组进行分类。我们使用多变量调查逻辑回归控制混杂变量,比较持续性与非持续性、复发性与稳定性、新发与从未发生。
随访时有 4966 名应答者:558 名有持续性症状,190 名有复发性症状,83 名符合 EPOS 标准的新 CRS 症状。持续性症状的患病率为 4.8%(95%CI,3.8-5.8),而新发症状的年累积发病率为 1.9%,复发性症状的发病率为 3.2%。基线时更严重的症状与持续性相关,而较轻的症状、过敏和多种治疗与新发症状的发展相关。
在我们的一般地区人群中,仅有不到一半的鼻-鼻窦症状符合 CRS EPOS 标准,其症状随时间持续存在,基线时的症状特征和发病年龄与症状的稳定性密切相关。